BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 17662905)

  • 41. Treatment of hyperpigmentation.
    Woolery-Lloyd H; Kammer JN
    Semin Cutan Med Surg; 2011 Sep; 30(3):171-5. PubMed ID: 21925372
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vitiligo treatment update.
    Daniel BS; Wittal R
    Australas J Dermatol; 2015 May; 56(2):85-92. PubMed ID: 25495880
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bridging Molecular Mechanism and Clinical Practice in Vitiligo Treatment: An Updated Review.
    Ju HJ; Bae JM
    Dermatology; 2024; 240(3):474-486. PubMed ID: 38417409
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Advanced treatment modalities for vitiligo.
    Patel NS; Paghdal KV; Cohen GF
    Dermatol Surg; 2012 Mar; 38(3):381-91. PubMed ID: 22288899
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of vitiligo.
    Nordlund JJ; Halder RM; Grimes P
    Dermatol Clin; 1993 Jan; 11(1):27-33. PubMed ID: 8435915
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Repigmentation of vitiligo with punch grafting and narrow-band UV-B (311 nm)--a prospective study.
    Lahiri K; Malakar S; Sarma N; Banerjee U
    Int J Dermatol; 2006 Jun; 45(6):649-55. PubMed ID: 16796620
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vitiligo management update.
    Westerhof W
    Skin Therapy Lett; 2000; 5(6):1-2,5. PubMed ID: 10889569
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of vitiligo patients with surgical interventions.
    Shokeen D
    Cutis; 2016 May; 97(5):E27-9. PubMed ID: 27274556
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Vitiligo--loss of cutaneous pigmentation].
    Sitek JC
    Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2370-2. PubMed ID: 16998548
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ultraviolet light in combination with other therapies for vitiligo: Synergy or necessity?
    Peterson D; King BA
    J Am Acad Dermatol; 2021 Jan; 84(1):e63-e64. PubMed ID: 32891783
    [No Abstract]   [Full Text] [Related]  

  • 51. Stable vitiligo treated by a combination of low-dose oral pulse betamethasone and autologous, noncultured melanocyte-keratinocyte cell transplantation.
    Mulekar SV
    Dermatol Surg; 2006 Apr; 32(4):536-41. PubMed ID: 16681662
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A rare repigmentation pattern in a vitiligo patient: a clue to an epidermal stem-cell reservoir of melanocytes?
    Davids LM; du Toit E; Kidson SH; Todd G
    Clin Exp Dermatol; 2009 Mar; 34(2):246-8. PubMed ID: 18828846
    [No Abstract]   [Full Text] [Related]  

  • 53. Use of the Q-switched 755-nm alexandrite laser to treat recalcitrant pigment after depigmentation therapy for vitiligo.
    Rao J; Fitzpatrick RE
    Dermatol Surg; 2004 Jul; 30(7):1043-5. PubMed ID: 15209798
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Validation study of the Vitiligo Extent Score-plus.
    van Geel N; Wolkerstorfer A; Lommerts JE; Ezzedine K; Eleftheriadou V; Hamzavi I; Harris J; Picardo M; Taieb A; Prinsen CAC; Bekkenk M; Speeckaert R
    J Am Acad Dermatol; 2018 May; 78(5):1013-1015. PubMed ID: 29180094
    [No Abstract]   [Full Text] [Related]  

  • 55. Different Advanced Therapeutic Approaches to Treat Vitiligo.
    Sharma CK; Sharma M; Aggarwal B; Sharma V
    J Environ Pathol Toxicol Oncol; 2015; 34(4):321-34. PubMed ID: 26756425
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Melanocytes and keratinocytes transfer using sandpaper technique combined with dermabrasion for stable vitiligo.
    Quezada N; Machado Filho CA; De La Sotta P; Uribe P
    Dermatol Surg; 2011 Feb; 37(2):192-8. PubMed ID: 21324028
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of phototherapy in the surgical treatment of vitiligo: a systematic review.
    Lommerts JE; Uitentuis SE; Bekkenk MW; de Rie MA; Wolkerstorfer A
    J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):1427-1435. PubMed ID: 29573480
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dermatitis produced by applications of monobenzone in patients with active vitiligo.
    Nordlund JJ; Forget B; Kirkwood J; Lerner AB
    Arch Dermatol; 1985 Sep; 121(9):1141-4. PubMed ID: 2931053
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Koebner's phenomenon induced vitiligo following Nd:YAG laser epilation treatment in a woman with a past history of a Sutton nevus.
    Mavilia L; Mercuri SR
    Dermatol Ther; 2014; 27(6):355-6. PubMed ID: 25056010
    [No Abstract]   [Full Text] [Related]  

  • 60. Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial.
    Dell'Anna ML; Mastrofrancesco A; Sala R; Venturini M; Ottaviani M; Vidolin AP; Leone G; Calzavara PG; Westerhof W; Picardo M
    Clin Exp Dermatol; 2007 Nov; 32(6):631-6. PubMed ID: 17953631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.